Summary by Futu AI
WuXi Biologics (Cayman) Inc., filed a Next Day Disclosure Report on May 13, 2024, disclosing share repurchase activities for the period December 7, 2023 to May 13, 2024. The company has made several share repurchases during this period, but has not written them off. The last repurchase took place on May 13, 2024, and repurchased 2,261,000 shares at a price of HKD 13.9 to HKD 14.54 for a total cost of approximately HKD 31,967,150. Since the adoption of the Ordinary Resolution, the company has repurchased a total of 100,243,000 shares on the Hong Kong Stock Exchange, representing 2.35954% of the issued shares. Pharma Bio confirms that all repurchases comply with the provisions of the Main Board Listing Rules/GEM Listing Rules.